Current achievements in the production of complex biopharmaceuticals with moss bioreactors - PubMed
- ️Thu Dec 11 2859
Review
Current achievements in the production of complex biopharmaceuticals with moss bioreactors
Eva L Decker et al. Bioprocess Biosyst Eng. 2008 Jan.
Abstract
Transgenic plants are promising alternatives for the low-cost and safe pathogen-free production of complex recombinant pharmaceutical proteins (molecular farming). Plants as higher eukaryotes perform posttranslational modifications similar to those of mammalian cells. However, plant-specific protein N-glycosylation was shown to be immunogenic, a fact that represents a drawback for many plant systems in biopharmaceutical production. The moss Physcomitrella patens offers unique properties as a contained system for protein production. It is grown in the predominant haploid gametophytic stage as tissue suspension cultures in photobioreactors. Efficient secretory signals and a transient transfection system allow the secretion of freshly synthesized proteins to the surrounding medium. The key advantage of Physcomitrella compared to other plant systems is the feasibility of targeted gene replacements. By this means, moss strains with non-immunogenic humanized glycan patterns were created. Here we present an overview of the relevant aspects for establishing moss as a production system for recombinant biopharmaceuticals.
Similar articles
-
Decker EL, Reski R. Decker EL, et al. Curr Opin Plant Biol. 2004 Apr;7(2):166-70. doi: 10.1016/j.pbi.2004.01.002. Curr Opin Plant Biol. 2004. PMID: 15003217 Review.
-
Moss bioreactors producing improved biopharmaceuticals.
Decker EL, Reski R. Decker EL, et al. Curr Opin Biotechnol. 2007 Oct;18(5):393-8. doi: 10.1016/j.copbio.2007.07.012. Epub 2007 Sep 14. Curr Opin Biotechnol. 2007. PMID: 17869503 Review.
-
Decker EL, Wiedemann G, Reski R. Decker EL, et al. Methods Mol Biol. 2015;1321:213-24. doi: 10.1007/978-1-4939-2760-9_15. Methods Mol Biol. 2015. PMID: 26082225
-
Glycoprotein production in moss bioreactors.
Decker EL, Reski R. Decker EL, et al. Plant Cell Rep. 2012 Mar;31(3):453-60. doi: 10.1007/s00299-011-1152-5. Epub 2011 Sep 29. Plant Cell Rep. 2012. PMID: 21960098 Review.
-
Glyco-engineering of moss lacking plant-specific sugar residues.
Huether CM, Lienhart O, Baur A, Stemmer C, Gorr G, Reski R, Decker EL. Huether CM, et al. Plant Biol (Stuttg). 2005 May;7(3):292-9. doi: 10.1055/s-2005-837653. Plant Biol (Stuttg). 2005. PMID: 15912449
Cited by
-
Glyco-engineering for biopharmaceutical production in moss bioreactors.
Decker EL, Parsons J, Reski R. Decker EL, et al. Front Plant Sci. 2014 Jul 9;5:346. doi: 10.3389/fpls.2014.00346. eCollection 2014. Front Plant Sci. 2014. PMID: 25071817 Free PMC article. Review.
-
State of research in the field of the creation of plant vaccines for veterinary use.
Permyakova NV, Uvarova EA, Deineko EV. Permyakova NV, et al. Russ J Plant Physiol. 2015;62(1):23-38. doi: 10.1134/S1021443715010100. Epub 2015 Jan 4. Russ J Plant Physiol. 2015. PMID: 32214753 Free PMC article. Review.
-
Recombinant pharmaceuticals from microbial cells: a 2015 update.
Sanchez-Garcia L, Martín L, Mangues R, Ferrer-Miralles N, Vázquez E, Villaverde A. Sanchez-Garcia L, et al. Microb Cell Fact. 2016 Feb 9;15:33. doi: 10.1186/s12934-016-0437-3. Microb Cell Fact. 2016. PMID: 26861699 Free PMC article. Review.
-
Mishra R, Chandra R. Mishra R, et al. J Genet Eng Biotechnol. 2020 Dec 14;18(1):82. doi: 10.1186/s43141-020-00098-8. J Genet Eng Biotechnol. 2020. PMID: 33315155 Free PMC article.
-
Bacterial cell factories for recombinant protein production; expanding the catalogue.
Ferrer-Miralles N, Villaverde A. Ferrer-Miralles N, et al. Microb Cell Fact. 2013 Nov 18;12:113. doi: 10.1186/1475-2859-12-113. Microb Cell Fact. 2013. PMID: 24245806 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources